Dr. Thomas J. Webster

Dr. Thomas J. Webster |Clyto Access

Northeastern University, USA

Keynote Speaker

Expertise: Nanoscience and Nanotechnology, Nanomedicines

Biography:

Thomas J. Webster’s (H index: 81, Google Scholar) degrees are in chemical engineering from the University of Pittsburgh (B.S., 1995) and in biomedical engineering from Rensselaer Polytechnic Institute (M.S., 1997; Ph.D., 2000). Prof. Webster is the current director of the Nanomedicine Laboratories (currently at 23 members) and has completed extensive studies on the use of nanophase materials in medicine. He pioneered the use of nanomaterials to increase tissue growth, inhibit infection, and decrease inflammation. He was appointed Department Chair of Chemical Engineering at Northeastern University in 2012 in which the Department recently broke the record for the fastest increase in ranking over a five year period from the U.S. News and World Report. In his 17 years in academics, Prof. Websterhas graduated/supervised over 149 visiting faculty, clinical fellows, post-doctoral students, and thesis completing B.S., M.S., and Ph.D. students. To date, his lab group has generated over 13 textbooks, 68 book chapters, 376 invited presentations, at least 503 peer-reviewed literature articles and/or conference proceedings, at least 767 conference presentations, and 42 provisional or full patents. His research has led to the formation of 12 companies with 4 FDA approved nanomedicine products. He is the founding editor-in-chief of the International Journal of Nanomedicine (the first open-access, international journal in nanomedicine which has a 5-year impact factor of 5.03).Prof. Webster currently directs or co-directs several centers in the area of biomaterials: The Center for Natural and Tropical Biomaterials (Medellin, Colombia), The Center for Pico and Nanomedicine (Wenzhou China), and The International Materials Research Center (Soochow, China). He was named the Art Zafiropoulo Chair at Northeastern University for his contributions to nanomedicine in 2013. Prof. Webster has received numerous honors including but not limited to: 2012, Fellow, American Institute for Medical and Biological Engineering (AIMBE, representing the top 2% of all medical and biological engineers); 2013, Fellow, Biomedical Engineering Society; 2015, Wenzhou 580 Award; 2015, Zheijang 1000 Talent Program; 2016, International Materials Research Chinese Academy of Science Lee-Hsun Lecture Award; 2016, International College of Fellows, Biomaterials Science and Engineering; and 2016, ActaBiomaterialia Silver Award.He also served as the President of the U.S. Society For Biomaterials. He has appeared on BBC, NBC, ABC, Fox News, the Weather Channel, the Discovery Channel, and the recent special ‘Year Million’ TV series on National Geographic talking about the future of medicine and science.

Presentation:

Title: The Next Generation of Implants: Using Nanomedicine Without Drugs to Control Cell Responses

Abstract:

Nanotechnology (or the use of materials with one dimension less than 100 nm) has been revolutionizing the medical device field for several decades due to the ability of nanomaterials to circulate longer in the blood stream, penetrating cells and tissues, simultaneously detecting and treating disease, and targeting select cellular receptors. However, so far, nanotechnology has proven not to be the panacea for eliminating cancer, cardiovascular diseases, osteoporosis, neural diseases, and many other diseases. Issues such as toxicity, efficacy, drug loading, cost, and lengthy FDA approval times have still proven to be significant obstacles. This presentation will summarize recent advances in developing improved medical devices for faster approval by focusing on not changing chemistries, but altering surface energy of existing FDA approved chemistries at the nanoscale. Such approaches have led to improved interactions with mammalian cells (such as bone, cartilage, vascular, neural, bladder, etc. cells) and decreased interactions with immune cells (such as monocytes, macrophages, etc.) to minimize nanoparticle clearance.Studies focusing not just on traditional biodegradable polymers but also metal oxides will be covered. Approaches which have combined treatment with diagnosis (i.e., theranostics) will also be emphasized for orthopedic, neural, and cancer treatment.

Related Conferences :

2nd world summit on Nanotechnology and Nanomedicine Research